Total views : 251

Exploratory Study for Myocardial Infarction Clinical Pathway Compliance and Performance


  • Clinical Science Department, Faculty of Biosciences and Engineering, University Technology Malaysia, Skudai, Malaysia
  • IJN-UTM Cardiovascular Engineering, Clinical Science Department, Faculty of Biosciences and Medical Engineering University Technology Malaysia, Skudai, Malaysia


Objectives: Although Clinical Pathway (CP) standardizes the patient care, poor compliance remains. The consistency of the expert’s opinion on the CPs significance to the pattern of Clinical Pathway completeness was explored. Methods/Statistical Analysis: Mixed method and data triangulation were used in this study. Two types of data were collected from one hospital for STEMI (St Elevation Myocardial Infarction) patients. Primary (Survey) and secondary (CP filled documents) data were collected. Clinical Pathway content analyses with descriptive statistics were conducted using SPSS version 22. The influence of design on the completeness of the document was investigated. Findings: The content analysis revealed four main care processes in STEMI Clinical Pathway (Medical assessment and nursing, Medication therapy and treatment, Education nutrition and rehabilitation and outcome variance). We found differences in the design of the documents. Most of the experts (58%) agreed on the importance of time to treatment, while 35% of the respondents have a strong agreement on the importance of fast action to treatment and nothing should delay the intervention. CP1 was holding the highest ratio of documents completeness despite the fact that CP2 and CP3 are the improved version of CP1. Application/Improvements: The variance of the expert opinion from the real Clinical Pathway performance indicated inconsistency between the knowledge and practice. Further explanation for the phenomenon is recommended.


Clinical Pathway, Completeness, Experts, Myocardial Infarction

Full Text:

 |  (PDF views: 193)


  • Nieuwlaat R, Schwalm JD, Khatib R, Yusuf S. Why are we failing to implement effective therapies in Cardiovascular Disease? European Heart Journal. 2013 May; 34(17):1262– 9.
  • Rotter T, Kinsman L, James EL, Machete A, Gotha H, Willis J, Kegler J. Clinical Pathways: Effects on professional practice, patient outcomes, length of stay and hospital costs. The Cochrane Database of Systematic Reviews. 2010; 7:1–166.
  • Panella M, Marchisio S, Di Stanislao F. Reducing clinical variations with Clinical Pathways: Do pathways work? International Journal for Quality in Health Care. 2003 Dec; 15(6):509–21.
  • Pinder R, Petchey R, Shaw S, Carter Y. What’s in a care pathway? Towards a cultural cartography of the new NHS. Sociology of Health and Illness. 2005 Sep; 27(6):759–79.
  • Bender DE, Ewbank D. The focus group as a tool for health research. Issues in Design and Analysis. Health Transiter Review. 1994 Apr; 4(1):63–80.
  • Shinar D, Gross CR, Mohr JP, Caplan LR, Price TR, Wolf PA, Hier DB, Kase CS, Fishman IG, Wolf CL. Interobserver variability in the assessment of neurologic history and examination in the stroke data bank. Archives of Neurology. 1985 Jun; 42(6):557–65.


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.